The multiomics blueprint of the individual with the most extreme lifespan
Affiliations
- 1 Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 2 Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Department of Biosciences, Faculty of Science, Technology and Engineering, University of Vic - Central University of Catalonia (UVic-UCC), Vic, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.
- 3 Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain.
- 4 BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; Institute of Evolutionary Biology (IBE, UPF-CSIC), Department of Medicine and Life, Barcelona, Catalonia, Spain.
- 5 Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.
- 6 Cellular Systems Genomics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 7 Genomics Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; High Content Genomics and Bioinformatics (HCGB)-Germans Trias I Pujol Research Institute (IGTP), Badalona, Barcelona, Catalonia, Spain.
- 8 Genomics Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 9 Proteomics Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 10 Department of Economic, Financial and Actuarial Mathematics, University of Barcelona, Barcelona, Catalonia, Spain.
- 11 High Content Genomics and Bioinformatics (HCGB)-Germans Trias I Pujol Research Institute (IGTP), Badalona, Barcelona, Catalonia, Spain.
- 12 Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.
- 13 Los Angeles Gerontology Research Group, Los Angeles, CA, USA.
- 14 Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 15 Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Microarrays Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 16 Single Cell Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 17 Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.
- 18 Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA) and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
- 19 Bioinformatics and Bioimaging (BI-SQUARED) Research Group, Biosciences Department, Faculty of Science, Technology and Engineering, Universitat de Vic - Universitat Central de Catalunya, Vic, Catalunya, Spain.
- 20 Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Catalonia, Spain.
- 21 Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Catalonia, Spain; Infectious diseases and Microbiome Unit, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Catalunya, Spain.
- 22 Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Catalonia, Spain; Biology Department, Universitat de Girona, Girona, Catalunya, Spain.
- 23 Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Catalonia, Spain; Digestive Service, Hospital Universitari de Girona Dr Josep Trueta, Girona, Catalunya, Spain.
- 24 Biosfer Teslab, 43201 Reus, Tarragona, Spain.
- 25 Universitat Rovira i Virgili, Department of Basic Medical Sciences, Reus, Spain; Institut d'Investigació Sanitària Pere Virgili, Reus, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
- 26 Biosfer Teslab, 43201 Reus, Tarragona, Spain; Universitat Rovira i Virgili, Department of Basic Medical Sciences, Reus, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
- 27 Institut d'Investigació Sanitària Pere Virgili, Reus, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Universitat Rovira i Virgili, Department of Electronic Engineering, Tarragona, Spain.
- 28 Telomeres and Telomerase Group - Fundación Humanismo y Ciencia, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain.
- 29 Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ, USA.
- 30 Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ, USA; Coit Center for Longevity and Neurotherapeutics, The University of Arizona, Tucson, AZ, USA.
- 31 BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; epi4health, Faculty of Health Sciences, Universitat Oberta de Catalunya, 08018 Barcelona, Catalonia, Spain.
- 32 epi4health, Faculty of Health Sciences, Universitat Oberta de Catalunya, 08018 Barcelona, Catalonia, Spain.
- 33 Mechanisms of Cancer and Aging Laboratory, Department of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK; University of Raparin, Kurdistan Region, Iraq.
- 34 Department of Cardiovascular Sciences, College of Life Sciences, University of Leicester, Leicester LE1 7RH, UK; National Institute for Health and Care Research Leicester Biomedical Research Centre, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester LE3 9QP, UK; Leicester van Geest MultiOMICS Facility, University of Leicester, Leicester LE1 7RH, UK.
- 35 Department of Cardiovascular Sciences, College of Life Sciences, University of Leicester, Leicester LE1 7RH, UK; Leicester van Geest MultiOMICS Facility, University of Leicester, Leicester LE1 7RH, UK.
- 36 Leicester van Geest MultiOMICS Facility, University of Leicester, Leicester LE1 7RH, UK; Leicester Cancer Research Centre, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, University of Leicester, Leicester LE1 5WW, UK.
- 37 BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; epi4health, Faculty of Health Sciences, Universitat Oberta de Catalunya, 08018 Barcelona, Catalonia, Spain; Mechanisms of Cancer and Aging Laboratory, Department of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK.
- 38 Institute of Evolutionary Biology (IBE, UPF-CSIC), Department of Medicine and Life, Barcelona, Catalonia, Spain; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, PRBB, Barcelona, Spain.
- 39 Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.
- 40 BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain.
- 41 Department of Medicine and Life Sciences, Universitat Pompeu Fabra, PRBB, Barcelona, Spain; Hospital Universitari Institut Pere Mata (HUIPM), Institut d'Investigació Sanitària Pere Virgili (IISPV), Universitat Rovira i Virgili (URV), Catalonia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
- 42 BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, PRBB, Barcelona, Spain.
- 43 BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; Institute of Evolutionary Biology (IBE, UPF-CSIC), Department of Medicine and Life, Barcelona, Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA) and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, PRBB, Barcelona, Spain; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.
- 44 Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA) and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain. Electronic address: mesteller@carrerasresearch.org.
- PMID: 40997805
- DOI: 10.1016/j.xcrm.2025.102368
The multiomics blueprint of the individual with the most extreme lifespan
Authors
Affiliations
- 1 Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 2 Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Department of Biosciences, Faculty of Science, Technology and Engineering, University of Vic - Central University of Catalonia (UVic-UCC), Vic, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.
- 3 Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain.
- 4 BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; Institute of Evolutionary Biology (IBE, UPF-CSIC), Department of Medicine and Life, Barcelona, Catalonia, Spain.
- 5 Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.
- 6 Cellular Systems Genomics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 7 Genomics Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; High Content Genomics and Bioinformatics (HCGB)-Germans Trias I Pujol Research Institute (IGTP), Badalona, Barcelona, Catalonia, Spain.
- 8 Genomics Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 9 Proteomics Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 10 Department of Economic, Financial and Actuarial Mathematics, University of Barcelona, Barcelona, Catalonia, Spain.
- 11 High Content Genomics and Bioinformatics (HCGB)-Germans Trias I Pujol Research Institute (IGTP), Badalona, Barcelona, Catalonia, Spain.
- 12 Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.
- 13 Los Angeles Gerontology Research Group, Los Angeles, CA, USA.
- 14 Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 15 Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Microarrays Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 16 Single Cell Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- 17 Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.
- 18 Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA) and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
- 19 Bioinformatics and Bioimaging (BI-SQUARED) Research Group, Biosciences Department, Faculty of Science, Technology and Engineering, Universitat de Vic - Universitat Central de Catalunya, Vic, Catalunya, Spain.
- 20 Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Catalonia, Spain.
- 21 Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Catalonia, Spain; Infectious diseases and Microbiome Unit, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Catalunya, Spain.
- 22 Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Catalonia, Spain; Biology Department, Universitat de Girona, Girona, Catalunya, Spain.
- 23 Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Catalonia, Spain; Digestive Service, Hospital Universitari de Girona Dr Josep Trueta, Girona, Catalunya, Spain.
- 24 Biosfer Teslab, 43201 Reus, Tarragona, Spain.
- 25 Universitat Rovira i Virgili, Department of Basic Medical Sciences, Reus, Spain; Institut d'Investigació Sanitària Pere Virgili, Reus, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
- 26 Biosfer Teslab, 43201 Reus, Tarragona, Spain; Universitat Rovira i Virgili, Department of Basic Medical Sciences, Reus, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
- 27 Institut d'Investigació Sanitària Pere Virgili, Reus, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Universitat Rovira i Virgili, Department of Electronic Engineering, Tarragona, Spain.
- 28 Telomeres and Telomerase Group - Fundación Humanismo y Ciencia, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain.
- 29 Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ, USA.
- 30 Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ, USA; Coit Center for Longevity and Neurotherapeutics, The University of Arizona, Tucson, AZ, USA.
- 31 BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; epi4health, Faculty of Health Sciences, Universitat Oberta de Catalunya, 08018 Barcelona, Catalonia, Spain.
- 32 epi4health, Faculty of Health Sciences, Universitat Oberta de Catalunya, 08018 Barcelona, Catalonia, Spain.
- 33 Mechanisms of Cancer and Aging Laboratory, Department of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK; University of Raparin, Kurdistan Region, Iraq.
- 34 Department of Cardiovascular Sciences, College of Life Sciences, University of Leicester, Leicester LE1 7RH, UK; National Institute for Health and Care Research Leicester Biomedical Research Centre, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester LE3 9QP, UK; Leicester van Geest MultiOMICS Facility, University of Leicester, Leicester LE1 7RH, UK.
- 35 Department of Cardiovascular Sciences, College of Life Sciences, University of Leicester, Leicester LE1 7RH, UK; Leicester van Geest MultiOMICS Facility, University of Leicester, Leicester LE1 7RH, UK.
- 36 Leicester van Geest MultiOMICS Facility, University of Leicester, Leicester LE1 7RH, UK; Leicester Cancer Research Centre, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, University of Leicester, Leicester LE1 5WW, UK.
- 37 BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; epi4health, Faculty of Health Sciences, Universitat Oberta de Catalunya, 08018 Barcelona, Catalonia, Spain; Mechanisms of Cancer and Aging Laboratory, Department of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK.
- 38 Institute of Evolutionary Biology (IBE, UPF-CSIC), Department of Medicine and Life, Barcelona, Catalonia, Spain; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, PRBB, Barcelona, Spain.
- 39 Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.
- 40 BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain.
- 41 Department of Medicine and Life Sciences, Universitat Pompeu Fabra, PRBB, Barcelona, Spain; Hospital Universitari Institut Pere Mata (HUIPM), Institut d'Investigació Sanitària Pere Virgili (IISPV), Universitat Rovira i Virgili (URV), Catalonia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
- 42 BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, PRBB, Barcelona, Spain.
- 43 BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Catalonia, Spain; Institute of Evolutionary Biology (IBE, UPF-CSIC), Department of Medicine and Life, Barcelona, Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA) and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, PRBB, Barcelona, Spain; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.
- 44 Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA) and Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain. Electronic address: mesteller@carrerasresearch.org.
- PMID: 40997805
- DOI: 10.1016/j.xcrm.2025.102368
Abstract
Extreme human lifespan, exemplified by supercentenarians, presents a paradox in understanding aging: despite advanced age, they maintain relatively good health. To investigate this duality, we have performed a high-throughput multiomics study of the world's oldest living person, interrogating her genome, transcriptome, metabolome, proteome, microbiome, and epigenome, comparing the results with larger matched cohorts. The emerging picture highlights different pathways attributed to each process: the record-breaking advanced age is manifested by telomere attrition, abnormal B cell population, and clonal hematopoiesis, whereas absence of typical age-associated diseases is associated with rare European-population genetic variants, low inflammation levels, a rejuvenated bacteriome, and a younger epigenome. These findings provide a fresh look at human aging biology, suggesting biomarkers for healthy aging, and potential strategies to increase life expectancy. The extrapolation of our results to the general population will require larger cohorts and longitudinal prospective studies to design potential anti-aging interventions.
Keywords: aging; epigenetics; genetics; microbiome; supercentenarian.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests M.E. declares past grants from Ferrer International and Incyte and personal fees from Quimatryx and Eucerin, outside of the submitted work.
LinkOut - more resources
Full Text Sources